Day: March 26, 2020

TORONTO, March 26, 2020 (GLOBE NEWSWIRE) — Feronia Inc. (“Feronia” or the “Company”) (TSXV: FRN) is pleased to announce that its wholly-owned subsidiary, Feronia Maia Srl, has entered into a loan facility for $4.5 million. All amounts in this press release are expressed in US dollars unless otherwise indicated.The unsecured subordinated short term facility bears interest at a rate of 4% per annum and has been provided by CDC Group plc, the UK Government’s development finance institution. The facility matures on June 30, 2020, subject to acceleration in certain circumstances.Funds advanced under the facility will be used for working capital, including environmental, social and governance improvements and other general corporate purposes, whilst the Company seeks to strengthen its financial position. This new facility is in addition...

JERSEY CITY, N.J., March 26, 2020 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that Dr. Nkechi Azie, SCYNEXIS’s VP of Clinical Development will deliver a live presentation on the Candida auris treatment landscape at the 22nd Annual Superbugs and Superdrugs Conference 2020, taking place virtually on March 30th and 31st.Presentation Details:“Candida auris is unlike any fungal infection we have seen in the past. It is difficult to identify and frequently resistant to at least two of the three available antifungal drug classes. It can persist on surfaces in healthcare settings, spreads easily between hospitalized patients, and is particularly deadly for immunocompromised patients,” said...

Contributes $1 million to National Restaurant Association Educational Foundation, $500K to U.S. Bartenders’ Guild, and $250K to support first respondersEstablishes company COVID-19 Relief Fund and will match employee contributions 2:1Launches employee effort to support local restaurants via take-out and delivery ordersVICTOR, N.Y., March 26, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, in partnership with a number of its iconic beer, wine, and spirits brands, announced today a collective commitment of more than $2.5 million to COVID-19 relief efforts.“Our hearts go out to the many individuals and businesses impacted by this terrible virus,” said Bill Newlands, president and chief executive officer, Constellations Brands. “Many of our retailer partners, particularly...

DALLAS, March 26, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced two new utility awards with a combined value over $35 million.  The contracts were secured by Q3 Contracting and ARB Underground, both part of the Utilities & Distribution segment. The first award is for the replacement of approximately 2 miles of 16” pipeline in Southern California.  Work commenced in the first quarter of 2020, and completion is expected in the second quarter of 2020.The second award is for the installation of approximately 25,000 feet of 20” pipeline in southeastern Minnesota.  Work is scheduled to commence in the second quarter of 2020, and completion is expected in the third quarter of 2020.ABOUT PRIMORISFounded in 1960, Primoris, through various subsidiaries, has...

EMERYVILLE, Calif., March 26, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and the Coalition for Epidemic Preparedness Innovations (CEPI) today announced a collaboration supporting the global effort to develop a vaccine to prevent the coronavirus (COVID-19). Dynavax will make the Company’s proprietary toll-like receptor 9 (TLR9) agonist adjuvant, CpG 1018TM, available for the development of effective vaccines against COVID-19.CpG 1018 is the adjuvant used in HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], an adult hepatitis B vaccine approved by the U.S. Food and Drug Administration (FDA). Dynavax developed CpG 1018 to provide an increased vaccine immune response, which has been demonstrated in HEPLISAV-B....

Heidelberg, Germany, March 26, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that the company will participate in the following upcoming virtual investor conferences.Dr. Adi Hoess, Chief Executive Officer, will present at the Solebury Trout Virtual Global Healthcare Conference Series on Thursday, April 2, 2020 at 9:30 a.m. Eastern Time. The presentation will be webcast live and available for replay in the investor relations section of Affimed’s website at https://www.affimed.com/investors/webcasts_cp/.  Dr. Adi Hoess will conduct virtual one-on-one meetings with institutional investors at the 2020 Wells Fargo Biotech Corporate Access Day on Tuesday, April 7, 2020.About Affimed N.V.Affimed (Nasdaq: AFMD) is a clinical-stage...

PRINCETON, N.J., March 26, 2020 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (the “Company” or “Clearway Energy”) today announced that, due to the emerging public health impact of the COVID-19 (Coronavirus) pandemic, the location of the Company’s 2020 annual meeting of stockholders (the “Annual Meeting”) has been changed from an in-person meeting to a virtual meeting. As previously announced, the Annual Meeting will still be held at 9:00 a.m., Eastern Time, on Thursday, April 30, 2020, but will be held only in a virtual meeting format.On March 24, 2020, the Company’s Board of Directors (the “Board”) approved the change to the location and format of the Annual Meeting in support of the health and well-being of the Company’s employees, stockholders and other associates, as well as the related protocols that have been...